Comparative analysis of the angiotensin-II receptor in placental vascular endothelial cells in preeclamptic and normotensive patients

Gynecologic and Obstetric Investigation

Volumn 56, Issue 1, 2003, Pages 55-60

  Laskowska, Marzena ^a   Vinson, Gavin P ^b   Szumiło, Justyna ^a   Laskowska, Katarzyna ^a   Leszczyńska Gorzelak, Bozena ^a   Oleszczuk, Jan ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiotensin II receptors; Endothelial cells; Placenta; Preeclampsia

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PLACENTA CIRCULATION; PREECLAMPSIA; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ALDOSTERONE; ANGIOTENSIN II; APGAR SCORE; BIRTH WEIGHT; BLOOD PRESSURE; ENDOTHELIAL CELLS; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 0042925329     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072704     Document Type: Article

References (24)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, Mc Laughlin MK: Präeklampsie: Eine Störung der Endothelzellen. Gynäkologe 1992;25:2-6.
2. Allaire AD, Ballenger KA, Wells SR, Mcmahon MJ, Lessey BA: Placental apoptosis in preeclampsia. Obstet Gynecol 2000;96:271-276.
3. Cooper AC, Robinson G, Vinson GP, Cheung WT, Broughton Pipkin F: The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy. Placenta 1999;20:467-474.
4. Goodfriend TL,Elliott ME, Catt KJ: Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-1654.
5. Csikós T, Gallinat S, Unger T: Extrarenal aspects of angiotensin II function. Eur J Endocrinol 1997;136:349-358.
6. Fernandez LA, Twickler J, Mead A: Neovascularization produced by angiotensin II. J Lab Clin Med 1985;105:141-145.
7. Le Noble FAC, Hekking JWM, Van Straaten HWM, Slaaf DW, Struyker Boudier HAJ: Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991;195:305-306.
8. Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-756.
9. Delafontaine P, Lou H: Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J Biol Chem 1993;268:16866-16870.
10. Essig M, Dussaule JC, Vandermeersch S, Chatziantoniou Ch, Ardaillou R: Modulation by angiotensin II of endothelial cell control of DNA synthesis in human mesangial cells. Nephron 1997;75:303-309.
11. Spatz M, Stanimirovic D, Bucic F, Uematsu S, McCarron RM: Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebrovascular endothelium. Am J Physiol 1994;266:C654-660.
12. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy: Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
13. Barker S, Marchant W, Ho MM, Puddenfoot JR, Hinson JP, Clark AJL, Vinson GP: A monoclonal antibody to a conserved sequence in the extracellular domain recognizes the angiotensin II AT1 receptor in mammalian tissues. J Mol Endocrinol 1993;11:241-245.
14. Bergqvist A, Ferno M, Skoog L: Quantitative enzyme immunoassay and semiquantitative immunohistochemistry of oestrogen and progesterone receptors in endometriotic tissue and endometrium. J Clin Pathol 1997;50:496-500.
15. Miturski R, Semczuk A, Postawski K, Jakowicki JA: Epidermal growth factor receptor immunostaining and epidermal growth factor receptor-tyrosine kinase activity in proliferative and neoplastic human endometrium. Tumor Biol 2000;21:358-366.
16. Nyholm HC, Nielsen AL, Lyndrup J, Norup P, Thorpe SM: Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: Correlations with stage and other clinicopathologic features. Am J Obstet Gynecol 1992;167:1334-1342.
17. Broughton-Pipkin F: Genetics of pre-eclampsia: Ideas of the turn of the millenium. Curr Obstet Gynaecol 1999;9:178-182.
18. Konijnenberg A, van der Post JAM, Mol BW, Schaap MCL, Lazarow R, Bleker OP, Boer K, Sturk A: Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Am J Obstet Gynecol 1997;177:434-442.
19. Craven CM, Morgan T, Ward K: Decidual spiral artery remodelling begins before cellular interaction with cytotrofoblasts. Placenta 1998;19:241-252.
20. Morgan T, Craven C, Ward K: Human spiral artery renin-angiotensin system. Hypertension 1998;32:683-687.
21. Morgan T, Craven C, Lalouel JM, Ward K: Angiotensinogen thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999;180:95-102.
22. Doering TP, Haller NA, Montgomery MA, Freeman EJ, Hopkins MP: The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1998;178:1307-1312.
23. Pouliot L, Forest JC, Moutquin JM, Coulombe N, Massé J: Platelet angiotensin II binding sites and early detection of preeclampsia. Obstet Gynecol 1998;91:591-595.
24. Laskowska M, Leszczyńska-Gorzelak B, Oleszczuk J: Evaluation of the platelet angiotensin II receptor in pregnancy complicated by preeclampsia. Gin Pol 2001;72 (12):1198-1204.